Provided by Tiger Fintech (Singapore) Pte. Ltd.

STRUCTURE THERAPEUTICS INC SPON ADS EACH REP 3 ORD

19.25
+0.42502.26%
Volume:151.03K
Turnover:2.87M
Market Cap:1.11B
PE:-6.17
High:19.25
Open:18.75
Low:18.75
Close:18.82
52wk High:45.37
52wk Low:13.22
Shares:57.60M
Float Shares:44.53M
Volume Ratio:0.46
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1192
EPS(LYR):-2.3276
ROE:-21.14%
ROA:-15.57%
PB:1.44
PE(LYR):-8.27

Loading ...

Septerna to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Yesterday

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Receives a Buy from Citi

TIPRANKS
·
Aug 18

Structure Therapeutics (GPCR) Falls Deeper into Losses and Seeks $250M—Is Its Funding Model Sustainable?

Simply Wall St.
·
Aug 17

BMO Capital Remains a Buy on Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
Aug 14

Septerna Highlights Business Progress and Reports Second Quarter 2025 Financial Results

GlobeNewswire
·
Aug 12

Structure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08

Eli Lilly Dives 14% On A Shocking Obesity Setback, Sending Its Rivals Flying

Blockhead
·
Aug 07

Structure Therapeutics Inc : H.c. Wainwright Cuts Target Price to $60 From $75

THOMSON REUTERS
·
Aug 07

Structure Therapeutics : Sales Agreement Prospectus Covers Offering of up to $250 Mln Adss Representing Ordinary Shares

THOMSON REUTERS
·
Aug 07

Structure Therapeutics Q2 EPS $(0.36) Misses $(0.25) Estimate

Benzinga
·
Aug 07

Structure Therapeutics Inc - Holds $786.5 Mln in Cash and Investments as of June 30 - SEC Filing

THOMSON REUTERS
·
Aug 07

Structure Therapeutics Inc - Accg-2671 Phase 1 Study to Start by Year-End 2025

THOMSON REUTERS
·
Aug 07

Structure Therapeutics Inc - Has $786.5 Mln Cash to Fund Operations Through 2027

THOMSON REUTERS
·
Aug 07

Structure Therapeutics Inc. Q2 Operating Expenses USD 70.451 Million

THOMSON REUTERS
·
Aug 07

Structure Therapeutics Inc - Aleniglipron Access Studies Data Expected by Year-End 2025

THOMSON REUTERS
·
Aug 07

Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

THOMSON REUTERS
·
Aug 07

Structure Therapeutics Inc expected to post a loss of 28 cents a share - Earnings Preview

Reuters
·
Aug 05

Structure Therapeutics initiated with a Buy at Clear Street

TIPRANKS
·
Jul 31

H.C. Wainwright Sticks to Its Buy Rating for Structure Therapeutics, Inc. Sponsored ADR (GPCR)

TIPRANKS
·
Jul 14

Structure Therapeutics, Inc. Sponsored ADR (GPCR) Gets a Buy from Guggenheim

TIPRANKS
·
Jun 26